leadership
confidence high
sentiment neutral
materiality 0.35
Labcorp corrects transposed equity award values for Caveney appointment; salary $650K
LABCORP HOLDINGS INC.
- Corrected RSU and stock option awards each valued at $67,000 (were transposed).
- Corrected performance share award value of $201,000.
- Base salary increased to $650,000 effective May 1, 2023.
- Caveney appointed EVP, President Early Development & Chief Medical and Scientific Officer.
- Role part of internal restructuring for planned spin-off of clinical development business.